MTOR and tuberous sclerosis: Although, our case-series was not powered for this comparison and the difference was not statistically significant, the trend observed was consistent with the reported effect of mTOR inhibitors on PNET growth in TSC and is the basis for the recommendation of its use on advanced PNETs (49).